Continuing disparities in cardiovascular risk factors and complications between aboriginal and Anglo-Celt Australians with type 2 diabetes: The fremantle diabetes study

Diabetes Care

Volumn 35, Issue 10, 2012, Pages 2005-2011

  Davis, Timothy M E ^a   Hunt, Kerry ^a   McAullay, Daniel ^b   Chubb, Stephen A P ^c   Sillars, Brett A ^a   Bruce, David G ^a   Davis, Wendy A ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b Aboriginal Health Council of Western Australia   (Australia)

^c ROYAL PERTH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABORIGINE; ADULT; AGE; AGED; ANKLE BRACHIAL INDEX; ARTICLE; AUSTRALIA; CARDIOVASCULAR RISK; DYSLIPIDEMIA; EDUCATIONAL STATUS; ETHNIC DIFFERENCE; FEMALE; GLYCEMIC CONTROL; HEALTH DISPARITY; HUMAN; LEG AMPUTATION; LONGITUDINAL STUDY; MALE; MICROALBUMINURIA; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREVALENCE; SELF REPORT; SMOKING; URBAN POPULATION;

ADULT; AGED; AUSTRALIA; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OCEANIC ANCESTRY GROUP; RISK FACTORS; SMOKING;

EID: 84866635688     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-0225     Document Type: Article

References (40)

1. Minges KE, Zimmet P, Magliano DJ, Dunstan DW, Brown A, Shaw JE. Diabetes prevalence and determinants in Indigenous Australian populations: a systematic review. Diabetes Res Clin Pract 2011;93:139-149
2. McDermott RA, Li M, Campbell SK. Incidence of type 2 diabetes in two indigenous Australian populations: a 6-year follow-up study. Med J Aust 2010;192:562-565
3. Maple-Brown LJ, Sinha AK, Davis EA. Type 2 diabetes in indigenous Australian children and adolescents. J Paediatr Child Health 2010;46:487-490
4. O'Neal DN, Piers LS, Iser DM, et al. Australian Aboriginal people and Torres Strait Islanders have an atherogenic lipid profile that is characterised by low HDL-cholesterol level and small LDL particles. Atherosclerosis 2008;201:368-377
5. Thomas M, Weekes AJ, Thomas MC. The management of diabetes in indigenous Australians from primary care. BMC Public Health 2007;7:303
6. Weil EJ, Nelson RG. Kidney disease among the indigenous peoples of Oceania. Ethn Dis 2006;16(Suppl. 2):24-30
7. Landers J, Henderson T, Craig J. Prevalence and associations of cataract in indigenous Australians within central Australia: the Central Australian Ocular Health Study. Clin Experiment Ophthalmol 2010;38:387-392
8. Wang Z, Hoy WE. Association between diabetes and coronary heart disease in Aboriginal people: are women disadvantaged? Med J Aust 2004;180:508-511
9. Ewald D, Patel M, Hall G. Hospital separations indicate increasing need for prevention of diabetic foot complications in central Australia. Aust J Rural Health 2001;9:275-279
10. Davis TM, McAullay D, Davis WA, Bruce DG. Characteristics and outcome of type 2 diabetes in urban Aboriginal people: the Fremantle Diabetes Study. Intern Med J 2007;37:59-63
11. Dodd AH, Colby MS, Boye KS, Fahlman C, Kim S, Briefel RR. Treatment approach and HbA1c control among US adults with type 2 diabetes: NHANES 1999-2004. Curr Med Res Opin 2009;25:1605-1613
12. Ford ES. Trends in the control of risk factors for cardiovascular disease among adults with diagnosed diabetes: findings from the National Health and Nutrition Examination Survey 1999-2008. J Diabetes 2011;3:337-347
13. Kuznik A, Mardekian J. Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-2008. Cardiovasc Diabetol 2011;10:31
14. Ford ES. Trends in the risk for coronary heart disease among adults with diagnosed diabetes in the U.S.: findings from the National Health and Nutrition Examination Survey, 1999-2008. Diabetes Care 2011;34:1337-1343
15. Hoerger TJ, Zhang P, Segel JE, Gregg EW, Narayan KM, Hicks KA. Improvements in risk factor control among persons with diabetes in the United States: evidence and implications for remaining life expectancy. Diabetes Res Clin Pract 2009;86:225-232
16. Chatterji P, Joo H, Lahiri K. Racial/ethnic- and education-related disparities in the control of risk factors for cardiovascular disease among individuals with diabetes. Diabetes Care 2012;35:305-312
17. McDermott RA, McCulloch BG, Campbell SK, Young DM. Diabetes in the Torres Strait Islands of Australia: better clinical systems but significant increase in weight and other risk conditions among adults, 1999-2005. Med J Aust 2007;186:505-508
18. O'Dea K, Rowley KG, Brown A. Diabetes in indigenous Australians: possible ways forward. Med J Aust 2007;186:494-495
19. Longstreet DA, Griffiths MM, Heath D, et al. Improving diabetes care in an urban Aboriginal medical centre. Aust J Prim Health 2005;11:25-31
20. Shortus TD, McKenzie SH, Kemp LA, Proudfoot JG, Harris MF. Multidisciplinary care plans for diabetes: how are they used? Med J Aust 2007;187:78-81
21. Davis TM, Zimmet P, Davis WA, Bruce DG, Fida S, Mackay IR. Autoantibodies to glutamic acid decarboxylase in diabetic patients from a multi-ethnic Australian community: the Fremantle Diabetes Study. Diabet Med 2000;17:667-674
22. Australian Bureau of Statistics. 1991 Census of Population and Housing. Basic Community Profile. Report No. 2722.0. Canberra, Commonwealth Government of Australia, 1997
23. Australian Bureau of Statistics. Census [Internet], 2006. Canberra, Commonwealth Government of Australia. Available from http://www.abs.gov.au/ websitedbs/censushome.nsf/home/Census. Accessed January 2012
24. Norman PE, Davis WA, Bruce DG, Davis TM. Peripheral arterial disease and risk of cardiac death in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care 2006;29:575-580
25. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D; Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999;130:461-470
26. Holman CD, Bass AJ, Rouse IL, Hobbs MST. Population-based linkage of health records in Western Australia: development of a health services research linked database. Aust NZ J Public Health 1999;23:453-459
27. Colagiuri S, Dickinson S, Girgis S, Colagiuri R. National Evidence Based Guideline for Blood Glucose Control in Type 2 Diabetes. Canberra, Diabetes Australia and the National Health and Medical Rsearch Council, 2009
28. McCulloch B, McDermott R, Miller G, Leonard D, Elwell M, Muller R. Selfreported diabetes and health behaviors in remote indigenous communities in Northern Queensland, Australia. Diabetes Care 2003;26:397-403
29. Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICROHOPE substudy. Lancet 2000;355:253-259
30. Collins R, Armitage J, Parish S, Sleigh P, Peto R; Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 2003;361:2005-2016
31. Colhoun HM, Betteridge DJ, Durrington PN, et al.; CARDS investigators. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS):multicentre randomised placebo-controlled trial. Lancet 2004;364:685-696
32. Australian Centre for Diabetes Strategies for the Diabetes Australia Guideline Development Consortium. National Evidence Based Guidelines for the Management of Type 2 Diabetes Mellitus. Part 7. Lipid Control in Type 2 Diabetes. Canberra, National Health and Medical Research Council, 2004
33. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984;102:527-532
34. Tesfaye S, Chaturvedi N, Eaton SE, et al.; EURODIAB Prospective Complications Study Group. Vascular risk factors and diabetic neuropathy. N Engl J Med 2005;352:341-350
35. Maple-Brown LJ, Cunningham J, Hodge AM, et al. High rates of albuminuria but not of low eGFR in urban indigenous Australians: the DRUID study. BMC Public Health 2011;11:346
36. Haluska BA, Chan L, Jeffriess L, Shaw AA, Shaw J, Marwick TH. Correlates of preclinical cardiovascular disease in indigenous and non-indigenous Australians: a case control study. Cardiovasc Ultrasound 2008;6:36
37. Maple-Brown LJ, Piers LS, O'Rourke MF, Celermajer DS, O'Dea K. Increased arterial stiffness in remote indigenous Australians with high risk of cardiovascular disease. J Hypertens 2007;25:585-591
38. Maple-Brown LJ, Cunningham J, Barry RE, et al. Impact of dyslipidaemia on arterial structure and function in urban indigenous Australians. Atherosclerosis 2009;202:248-254
39. Wang Z, Hoy WE, Si D. Incidence of type 2 diabetes in Aboriginal Australians: an 11-year prospective cohort study. BMC Public Health 2010;10:487
40. Simmons D. Impact of an integrated approach to diabetes care at the Rumbalara Aboriginal Health Service. Intern Med J 2003;33:581-585